(Bh4) Igt Devices Undivided
Payments companies reported to CMS as associated with (Bh4) Igt Devices Undivided. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (Bh4) Igt Devices Undivided, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (Bh4) Igt Devices Undivided
These are the largest totals companies reported as associated with (Bh4) Igt Devices Undivided. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jasvindar Singh | Saint Louis, MO | Interventional Cardiology | $35,422.82 |
| Karim Al-Azizi | Plano, TX | Interventional Cardiology | $16,461.52 |
| Bruce Samuels | Beverly Hills, CA | Cardiovascular Disease | $10,139.03 |
| Eric Secemsky | Boston, MA | Interventional Cardiology | $7,044.31 |
| Amir Lerman | Rochester, MN | Cardiovascular Disease | $2,519.96 |
| Sarang Mangalmurti | Bryn Mawr, PA | Cardiovascular Disease | $2,467.77 |
| Thuy Ryan | Myrtle Beach, SC | Interventional Cardiology | $2,461.91 |
| Robert Mendes | Raleigh, NC | Vascular Surgery | $2,421.80 |
| Michael Siah | Dallas, TX | Vascular Surgery | $2,380.82 |
| Fadi Saab | Grand Rapids, MI | Cardiovascular Disease | $2,363.70 |
Prescribed (Bh4) Igt Devices Undivided?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.